Milrinone Horizon 10mg/10 mL Concentrated Injection milrinone (as lactate)10mg/10 mL ampoule

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

milrinone, Quantity: 10 mg

Mevcut itibaren:

Generic Health Pty Ltd

INN (International Adı):

Milrinone

Farmasötik formu:

Injection, concentrated

Kompozisyon:

Excipient Ingredients: water for injections; lactic acid; sodium hydroxide; glucose

Uygulama yolu:

Intravenous

Paketteki üniteler:

10 ampoules, 1 ampoule

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

- Milrinone Horizon Concentrated Injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (eg. digoxin, diuretics, vasodilators, including ACE inhibitors). The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. - Milrinone Horizon Concentrated Injection is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Ürün özeti:

Visual Identification: Clear, colourless to pale yellow sterile solution, practically free from visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2013-11-29